Jack Elands is the founder of Emergence Therapeutics. Emergence Therapeutics has raised $94M in total funding. Latest round: Series A.
Jack Elands (Jacobus P. M. Elands) is a biopharmaceutical executive and founder specializing in antibody drug conjugates (ADCs) for cancer treatment. He is the CEO of Emergence Therapeutics, a European biopharma company, and previously founded Adcytherix SAS, another ADC startup.
Full founder directory · Investor directory · Company funding database · Fundraising library